[Form 4] GoodRx Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Agnes Rey-Giraud transferred 75,219 shares of GoodRx Holdings, Inc. (GDRX) Class A common stock to the ARG Family Legacy Trust #1 on 08/18/2025. The Form 4 shows the Reporting Person serves as sole trustee of the Trust and that members of her family are beneficiaries. After the transaction the filings indicate beneficial ownership entries reflecting the transfer; the Form 4 was signed by an attorney-in-fact on 08/19/2025. The document contains no information about sales, option exercises, or cash consideration beyond the transfer into the Trust.

Insights

Corporate Governance Expert

TL;DR Insider transferred shares into a family trust while retaining trustee role; common estate planning step, not necessarily a market event.

The transfer of 75,219 Class A shares to a family legacy trust, with the reporting person as sole trustee and family members as beneficiaries, aligns with routine estate and succession planning. The Form 4 discloses the change in direct versus indirect ownership but does not show any sale or cash proceeds. From a governance perspective, the transfer maintains control continuity within the family and preserves beneficial alignment with shareholders; it does not introduce new management, change in board composition, or a change in voting arrangements disclosed on this form.

Securities Analyst

TL;DR A non-sale transfer of 75,219 shares to a family trust was reported; this is informational and likely neutral for market valuation.

The Form 4 documents a gift/transfer rather than an open-market disposition or acquisition. There is no price listed and no derivative activity reported. For investors, the key datapoints are the number of shares transferred and that the reporting person still has an indirect beneficial interest via the Trust. The filing provides no indication of intent to monetize holdings or alter strategic direction, so immediate market impact appears limited based on the disclosed facts alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

REY-GIRAUD AGNES

(Last) (First) (Middle)

C/O GOODRX HOLDINGS, INC.

2701 OLYMPIC BOULEVARD

(Street)

SANTA MONICA CA 90404

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GoodRx Holdings, Inc. [ GDRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/18/2025		G		75,219(1)	D	$0	85,448	D
Class A Common Stock	08/18/2025		G		75,219(1)	A	$0	75,219(1)	I	By ARG Family Legacy Trust #1

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On August 18, 2025, the Reporting Person transferred 75,219 shares of Class A common stock to the ARG Family Legacy Trust #1 (the "Trust"). The Reporting Person serves as the sole trustee of the Trust, and the Reporting Person and other members of her family are the beneficiaries of the Trust.

Remarks:

	/s/ Gracye Cheng, Attorney-in-Fact for Agnes Rey-Giraud	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Agnes Rey-Giraud report on the Form 4 for GDRX?

She reported transferring 75,219 shares of Class A common stock to the ARG Family Legacy Trust #1 on 08/18/2025 and disclosed she is the sole trustee.

Was the transfer of GDRX shares a sale for cash?

No. The Form 4 shows a transfer to a family trust with a transaction code indicating a gift/transfer; no cash price is reported.

How many GDRX shares does the filing show after the transaction?

The filing lists 85,448 shares under one beneficial ownership line and 75,219 shares as held indirectly by the Trust, reflecting the reported transfer entries.

Who benefits from the ARG Family Legacy Trust #1?

The filing states the Reporting Person and other family members are beneficiaries of the Trust.

When was the Form 4 signed and filed?

The signature by attorney-in-fact is dated 08/19/2025. The transaction date reported is 08/18/2025.